Stay updated on Trastuzumab Emtansine in HER2+ Tumors Clinical Trial

Sign up to get notified when there's something new on the Trastuzumab Emtansine in HER2+ Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Trastuzumab Emtansine in HER2+ Tumors Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Added page revision v3.6.5 to replace v3.6.4, indicating a new version of the page has been published. This appears to reflect internal fixes or small tweaks rather than changes to the study details.
    Difference
    0.0%
    Check dated 2026-08-09T11:04:18.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.4, indicating an updated version of the record; this reflects administrative maintenance rather than a modification to the study details.
    Difference
    0.0%
    Check dated 2026-07-25T18:20:09.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    42 days ago
    Change Detected
    Summary
    The revision history shows a update to version v3.6.3, indicating a software/maintenance update to the page’s underlying system, with no changes to the displayed study data.
    Difference
    0.0%
    Check dated 2026-07-04T10:09:23.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The page's revision tag updated from v3.6.0 to v3.6.2, signaling a new version of the study documentation rather than a substantive update to trial details.
    Difference
    0.0%
    Check dated 2026-06-27T06:30:47.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The page adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates header labels (Intervention/Treatment) while removing the older label (Intervention / Treatment) and the older revision note (Revision: v3.5.5), and introduces a new revision version (Revision: v3.6.0). Additionally, recruitment status is updated with 'No longer looking for participants', indicating that enrollment is closed.
    Difference
    0.4%
    Check dated 2026-06-13T01:39:36.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.4 to v3.5.5, indicating a minor version update. No substantive study content or functionality changes are indicated by the provided data or screenshots.
    Difference
    0.0%
    Check dated 2026-06-05T22:02:34.000Z thumbnail image

Stay in the know with updates to Trastuzumab Emtansine in HER2+ Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Trastuzumab Emtansine in HER2+ Tumors Clinical Trial page.